These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 6500748

  • 1. Use of oral verapamil in long-term treatment of neonatal, paroxysmal supraventricular tachycardia. A pharmacokinetic study.
    de Vonderweid U, Benettoni A, Piovan D, Padrini R.
    Int J Cardiol; 1984 Nov; 6(5):581-6. PubMed ID: 6500748
    [Abstract] [Full Text] [Related]

  • 2. The use of calcium gluconate prior to verapamil in infants with paroxysmal supraventricular tachycardia.
    Roguin N, Shapir Y, Blazer S, Zeltzer M, Berant M.
    Clin Cardiol; 1984 Nov; 7(11):613-6. PubMed ID: 6499292
    [Abstract] [Full Text] [Related]

  • 3. [Intravenous verapamil for paroxysmal supraventricular tachycardia in Wolff-Parkinson-White syndrome].
    Nissimov R.
    Harefuah; 1982 Mar 15; 102(6):234-7. PubMed ID: 7160717
    [No Abstract] [Full Text] [Related]

  • 4. Combination therapy with aprindine and verapamil for paroxysmal supraventricular tachycardia as assessed by transesophageal atrial pacing.
    Hirao K, Okishige K, Suzuki F, Hiejima K.
    Cardiovasc Drugs Ther; 1991 Aug 15; 5 Suppl 4():819-25. PubMed ID: 1931758
    [Abstract] [Full Text] [Related]

  • 5. Intravenous verapamil in the treatment of paroxysmal supraventricular tachycardia in children.
    Leitner RP, Hawker RE, Celermajer JM.
    Aust Paediatr J; 1983 Mar 15; 19(1):40-4. PubMed ID: 6870700
    [Abstract] [Full Text] [Related]

  • 6. Verapamil in the treatment of paroxysmal supraventricular tachycardia.
    Krikler DM, Spurrell RA.
    Postgrad Med J; 1974 Jul 15; 50(585):447-53. PubMed ID: 4469035
    [Abstract] [Full Text] [Related]

  • 7. Acute and chronic effects of verapamil in patients with paroxysmal supraventricular tachycardia.
    Sakurai M, Yasuda H, Kato N, Nomura A, Fujita M, Nishino T, Fujita K, Koike Y, Saito H.
    Am Heart J; 1983 Apr 15; 105(4):619-28. PubMed ID: 6837416
    [Abstract] [Full Text] [Related]

  • 8. Oral verapamil for paroxysmal supraventricular tachycardia: a long-term, double-blind randomized trial.
    Mauritson DR, Winniford MD, Walker WS, Rude RE, Cary JR, Hillis LD.
    Ann Intern Med; 1982 Apr 15; 96(4):409-12. PubMed ID: 7065555
    [Abstract] [Full Text] [Related]

  • 9. [Verapamil in the study and treatment of supraventricular tachycardias, with special reference to pre-excitation].
    Krikler DM.
    Minerva Med; 1975 May 26; 66(39):1914-22. PubMed ID: 236526
    [Abstract] [Full Text] [Related]

  • 10. Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group.
    DiMarco JP, Miles W, Akhtar M, Milstein S, Sharma AD, Platia E, McGovern B, Scheinman MM, Govier WC.
    Ann Intern Med; 1990 Jul 15; 113(2):104-10. PubMed ID: 2193560
    [Abstract] [Full Text] [Related]

  • 11. Transesophageal electropharmacologic test in a newborn with familial Wolff-Parkinson-White syndrome.
    Colloridi V, Boscioni M, Patruno N, Pulignano G, Critelli G.
    Pediatr Cardiol; 1990 Oct 15; 11(4):213-5. PubMed ID: 2274450
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the electrophysiologic effects of oral sustained-release and intravenous verapamil in patients with paroxysmal supraventricular tachycardia.
    Lai WT, Voon WC, Yen HW, Chang JS, Sheu SH, Hwang YS, Chiu HF.
    Am J Cardiol; 1993 Feb 15; 71(5):405-8. PubMed ID: 8430627
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [A randomized, multicenter trial to compare the safety and efficacy of adenosine versus verapamil for termination of paroxysmal supraventricular tachycardia].
    Cheng KA, Intravenous Adenosine versus Verapamil in Terminating Episodes of Paroxysmal Supraventricular Tachycardia Study Group.
    Zhonghua Nei Ke Za Zhi; 2003 Nov 15; 42(11):773-6. PubMed ID: 14636464
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of the electrophysiologic effects of intravenous and oral verapamil in patients with paroxysmal supraventricular tachycardia.
    Klein GJ, Gulamhusein S, Prystowsky EN, Carruthers SG, Donner AP, Ko PT.
    Am J Cardiol; 1982 Jan 15; 49(1):117-24. PubMed ID: 7053599
    [Abstract] [Full Text] [Related]

  • 20. Comparison of verapamil and practolol in paroxysmal supraventricular tachycardia.
    Härtel G, Hartikainen M.
    Eur J Cardiol; 1976 Mar 15; 4(1):87-90. PubMed ID: 1261584
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.